NVCT Expands Portfolio
Nuvectis announces strategic portfolio expansion via license agreement with Haisco Pharmaceutical Group for two clinical-stage compounds
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Nuvectis announces strategic portfolio expansion via license agreement with Haisco Pharmaceutical Group for two clinical-stage compounds